Cost benefit analysis of the diabetes self management program at a university health centre in Malaysia

Journal of Clinical and Diagnostic Research

Volumn 4, Issue 3, 2010, Pages 2521-2530

  Al Haddad, M ^a   Ibrahim, M M I ^a   Sulaiman, S A S ^a   Shafie, A A ^b   Maarup, N ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

CBA; Cost; DSMP; Malaysia; WTP

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HEALTH CENTER; HUMAN; KIDNEY FAILURE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PATIENT ATTITUDE; PROGRAM DEVELOPMENT; SELF CARE; SEX DIFFERENCE;

EID: 78650054818     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barrett EJ. Diabetes Epidemic Is a Worldwide Threat. Clin Diabetes. 2004 January 1, 2004;22(1):47-48.
2. First national health and morbidity survey. Malaysia:, Institute of Public Health, Ministry of Health 1985.
3. Second national health and morbidity survey. Malaysia:, Institute of Public Health, Ministry of Health 1996.
4. Zaini A. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus? Diabetes Research and Clinical Practice. 2000;50(Supplement 2):S23-S28.
5. Noyes K, Holloway RG. Evidence from Cost-Effectiveness Research. NeuroRX. 2004;1(3):348-355.
6. COOKSON R. Willingness to pay methods in health care: a skeptical view. Health Economics. 2003;12:891-894.
7. Zarnke KB, Levine MAH, O'Brien BJ. Cost-Benefit Analyses in the Health- Care Literature: Don't Judge a Study by Its Label. Journal of Clinical Epidemiology. 1997;50(7):813-822.
8. Zarkin GA, Cates SC, Bala MV. Estimating the willingness to pay for drug abuse treatment: A pilot study. Journal of Substance Abuse Treatment. 2000;18(2):149-159.
9. Blaine TW, Lichtkoppler FR, Jones KR, Zondag RH. An assessment of household willingness to pay for curbside recycling: A comparison of payment card and referendum approaches. Journal of Environmental Management. 2005;76(1):15-22.
10. Zhongmin X, Guodong C, Zhiqiang Z, Zhiyong S, Loomis J. Applying contingent valuation in China to measure the total economic value of restoring ecosystem services in Ejina region. Ecological Economics. 2003;44(2-3):345-358.
11. Jim CY, Chen WY. Recreationamenity use and contingent valuation of urban greenspaces in Guangzhou, China. Landscape and Urban Planning. 2006;75(1-2):81-96.
12. Birch S, Gafni A, O'Brien B. Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza. PharmacoEconomics. 1999;16(6):55-61.
13. Birch S, Donaldson C. Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? Social Science & Medicine. 2003; Sect. 1121.
14. Donaldson C, Hundley V, Mapp T, Donaldson C. Willingness To Pay: A Method For Measuring Preferences For Maternity Care? Birth: Issues in Perinatal Care. 1998;25(1):32-39.
15. Hashimoto K, Nakamura T, Wada I, Yoshida K, Satoh S, Abo M, et al. HOW GREAT IS WILLINGNESS TO PAY FOR RECOVERY FROM SEQUELAE AFTER SEVERE TRAUMATIC BRAIN INJURY IN JAPAN? Journal of Rehabilitation Medicine. 2006;38(2):141-143.
16. MD. Yusof FA. Cost Effectiveness Analysis of Erythropoietin Therapy in the Ministry of Health Dialysis Programme. Penang: University Sains Malaysia; 2006.
17. Bala MV, Mauskopf JA, Wood LL. Willingness to Pay as a Measure of Health Benefits. PharmacoEconomics. 1999;15(1):9-18.
18. Liu L, Neilson WS. Endogenous private health investment and the willingness to pay for public health projects: The effects of income. Economics Letters. 2005;87(3):415-420.
19. Asenso-Okyere WK, Osei-Akoto I, Anum A, Appiah EN. Willingness to pay for health insurance in a developing economy. A pilot study of the informal sector of Ghana using contingent valuation. Health Policy. 1997;42(3):223-237.
20. Sadri H, MacKeigan LD, Leiter LA, Einarson TR. Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach. PharmacoEconomics.2005;23(12):121 5-27.
21. Dong H, Kouyate B, Snow R, Mugisha F, Sauerborn R. Gender's effect on willingness-to-pay for community based insurance in Burkina Faso. Health Policy. 2003;64(2):153-162.
22. Ryan M, Scott DA, Donaldson C. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods. Journal of Health Economics. 2004;23(2):237-258.
23. Caro JJ, Ward AJ, O'Brien JA. Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care. 2002 March 1, 2002;25(3):476-481.
24. O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 1998 July 1, 1998;21(7):1122-1128.
25. Cote, I., Gregoire, J.-P., Moisan J, Chabot I, Lacroix G. A Pharmacy- Based Health Promotion Programme in Hypertension: Cost-Benefit Analysis. Pharmaco Economics. 2003;21(6):415-428.
26. Hackl F, Pruckner GJ. Demand and supply of emergency help: An economic analysis of Red Cross services. Health Policy. 2006;77(3):326-338.
27. Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Dobson M. Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach. PharmacoEconomics. 1998;13(3):347-358.